z-logo
open-access-imgOpen Access
Cathepsin S as a cancer target
Author(s) -
L. ZHANG,
H. WANG,
Jin Xu
Publication year - 2015
Publication title -
neoplasma
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.628
H-Index - 50
eISSN - 1338-4317
pISSN - 0028-2685
DOI - 10.4149/neo_2015_003
Subject(s) - cathepsin , cathepsin a , cathepsin s , cancer , angiogenesis , cancer research , proteases , metastasis , cathepsin e , cathepsin l , cathepsin o , basement membrane , chemistry , biology , medicine , microbiology and biotechnology , biochemistry , enzyme
Cathepsin S is a lysosomal enzyme that belongs to the papain family of cysteine proteases. Multiple studies indicate that cathepsin S acts not only as a crucial role in antigen presentation but also as an important protagonist of cancers. Cathepsin S has been shown to participate in dissolution and remodelling of connective tissue and basement membranes, resulting in the process of tumor growth, invasion, metastasis and angiogenesis. Therefore, cathepsin S has been suggested as a potential therapeutic target in cancer therapy. In the present study, we review the rapidly advancing field of cathepsin S in cancer therapy, highlighting the specific roles of cathepsin S in cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom